Our Customers Say:
“I have used Flavay® and Flavay Plus® for almost a month and I really have not felt this healthy since, God, for so long. Fantastic energy and better overall. I have ms (small letters intentional, I hate it) and am feeling better even at work, people have commented, and my skin is better than it has ever been. I have great energy, it is incredible. I get on the exercise bike for an hour a day instead of lying in bed like before. I doubted the possibility but after only a month I see results and others do too.”
—Mr. G. S.
"I have multiple sclerosis and I was taking Avonex
shots once a week, which not only cost me $1,000.00 per month but I felt
ill everyday except for the day prior to getting the next shot. Now that
I am taking Flavay® I have completely stopped the Avonex shots. I take
two Flavay® in the morning and two Flavay® in the evening, and all of my
symptoms have completely disappeared except for the numbness in my arm.
I am very happy with the results!"
—Ms. Kathy C.
"I have multiple sclerosis and I used to have to drink
three cups of coffee in the mornings just to get control over my speech,
which was slurred. With Flavay® and Flavay Plus®, my speech cleared up.
I don’t argue with success! My neighbor’s young son has autism,
he also takes Flavay® and Flavay Plus®, and his mother said that his speech
is clearing up and he poops in the toilet... The teacher asked, “What
are you doing?” She told her it was nutrition. The teacher repeated,
“What are you doing?” The teacher didn’t want to believe,
but could plainly see decided improvement in the boy."
—Ms. S. R.
Protected by U.S. PATENT NO. 4,698,360 and international patents.
Copyright © 1995-2010 Healthy Source, LLC. All rights reserved.
FAQ | DOSAGE Info | All About Flavay® | Flavay Plus® | What Does it Do? | Proven Safety
Ingredients | Comparative
Analysis | SEARCH | Endorsements & Testimonials | Contact Us
REFERENCES:
1. Masquelier, J. A lifetime devoted to OPC and pycnogenol. Alfa Omega
Editrice, Pub., 1996.
2. Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice,
Publishers, 1995.
3. Masquelier, J. Plant extract with
a proanthocyanidins content as a therapeutic agent having radical scavenging
effect and use thereof. U.S. Patent No. 4,698,360, 1987.
4. Lombard, J., (board certified neurologist), Germano, C. The Brain Wellness
Plan - Breakthrough Medical, Nutritional and Immune-Boosting Therapies to
Prevent and Treat Depression, Alzheimer's Disease, Chronic Fatigue Syndrome,
Attention Deficit Disorder, Multiple Sclerosis, Parkinson's Disease, Lou
Gehrig's Disease. Kensington Pub. Corp., 1998.
5. Packer, L., et al. The antioxidant miracle: your complete plan. John
Wiley & Sons, Inc., 1999.
6. Carper, J., Miracle Cures : Dramatic New Scientific Discoveries Revealing
the Healing Powers of Herbs, Vitamins, and Other Natural Remedies, HarperCollins
Publishers, 1998.
7. Weintraub, S., "Natural Treatments for ADD and Hyperactivity,"
Woodland Publishing, 1997.
8. Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
9. Kidd, P.M. Phosphatidylserine: the nutrient that accelerates all brain
functions and counters Alzheimer’s disease: Keats Pub. 1998.
10. Cenacchi T, et al. Cognitive decline in the elderly: A double-blind,
placebo-controlled multicenter study on efficacy of phosphatidylserine administration.
Aging, 5: 123–133, 1993.
11. Kidd, P.M. PhosphatidylSerine: Nature's Brain Booster: Total Health Communications, Inc. 2005.
12. O'Brien, C., "Answers to ADD," Vitamin Retailer, March 2002.
13. Cenacchi T, et al., “Cognitive decline in the elderly: A double-blind,
placebo-controlled multicenter study on efficacy of phosphatidylserine administration.”
Aging, 5, 123-133, 1993
14. Funfgeld, E.W., Baggen, M., Nedwidek, P., Richstein, B., Mistlberger,
G. Double-blind study with phosphatidylserine (PS) in parkinsonian patients
with senile dementia of Alzheimer’s type (SDAT). Prog Clin Biol Res,
317:1235-46, 1989.
15. Kaneko, M., et al., "Hypothalamic-putuitary-adrenal axis function
in children with attention deficit hyperactivity disorder." 120. The
Journal of Autism and Developmental Disorders, 1993 Mar; 23 (1): 59-65.
16. Monteleone P., Maj M., Beinat L., Natale M., Kemali, D. Blunting by
chronic phosphatidylserine administration of the stress-induced activation
of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm,
43: 385–388, 1992.
17. Kidd, P., "Phospholipids: life's buildling blocks." Vitamin
Retailer, Oct. 2002.
18. Benton, D, et al., Nutr Neurosci 2001;4;169.
19. Le Bars, P.L., Katz, M.M., Berman, N., Itil, T.M., Freedman, A.M., Schatzberg,
F.A. A placebo-controlled, double-blind, randomized trial of an extract
of ginkgo biloba for dementia. Journal of the Amer Med Assoc, 278 (16):1327-32,
1997.
20. Lieberman, S., et al. The real vitamin & mineral book: going beyond
the RDA. Avery Pub., 1990.
21. Mindell, E., et al. Earl Mindell’s vitamin bible for the 21st century.
Warner Books, Inc., 1999.
22. Cavagnini, F., et al. Effect of acute and repeated administration of
gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion
in man. Acta Endocrinol, 93:149–54, 1980.
23. Bhagavan, H.N., et al. The effect of pyridoxine hydrochloride on blood
serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics,
1975;55: 437-41.
24. ___. Along with riboflavin, vitamin B-6 deficiency has a primary role
in the cause of emotional disorder. British Journal of Psychiatry, 141(1982):271-272.
25. ___. Current data suggest that as many as 20 percent of medically cleared
population of outpatient depressives may suffer from a vitamin B-6 deficit.
The authors point out that nutrition, diet and vitamin levels have received
very little attention in the psychiatric literature. Biological Psychiatry,
9:4 (1984):613-6.
26. ___. Does depressive illness cause vitamin B-6 inadequacy, or vice-versa?
Nut Rep Int, 27 (Apr. 1993):867-873.
27. Martineau, J., et al. Vit. B6, magnesium, and combined B6-Mg: therapeutic
effects. Bio Psy, 20:467-78, 1985.
28. Dolphin, et al. (eds). Vitamin B6: pyridoxal phosphate. John Wiley &
Sons, 1986, chapt. 17.
29. Langseth, L., et al. Glucose tolerance and hyperkinesis. Food and Cosm
Toxicology, 16 Aug. 1977.
30. Bhagavan, H.N., et al. The effect of pyridoxine hydrochloride on blood
serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics,
1975;55: 437-41.
31. Martineau, J., et al. Vit. B6, magnesium, and combined B6-Mg: therapeutic
effects. Bio Psy, 20:467-78, 1985.
32. Passwater, R.A. The antioxidants: the nutrients that guard your body.
Keats Publishing, Inc., 1985.
33. Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
34. Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol.
25(2):135-9, 1987.
35. Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
36. Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
37. Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow
cells of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co.,
projects 143010 & 143021; Feb. 1989.
38. Acute and chronic toxicity tests. International Bio-Research, Inc.,
Hanover, Germany, 1967-1971.
39. Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in
vegetable extracts to be used in the preparation of medicines. Bull. Soc.
Pharm. Bordeaux, 129:51-65, 1990.
